Medical therapy for glaucoma: What to add after a prostaglandin analogs?

Angelo P. Tanna*, Albert B. Lin

*Corresponding author for this work

Research output: Contribution to journalReview article

11 Scopus citations

Abstract

For patients already on a PGA, the mean diurnal IOP-lowering achieved with the addition of an alpha2 adrenergic agonist, a beta adrenergic antagonist, or a topical carbonic anhydrase inhibitor is similar, whereas the side-effect profiles, nocturnal IOP-lowering efficacy, and trough IOP-lowering effects vary. Laser trabeculoplasty is also an effective means of further lowering the IOP in patients on a PGA.

Original languageEnglish (US)
Pages (from-to)116-120
Number of pages5
JournalCurrent opinion in ophthalmology
Volume26
Issue number2
DOIs
StatePublished - Jan 1 2015

Keywords

  • Alpha adrenergic agonist
  • Beta adrenergic antagonist
  • Carbonic anhydrase inhibitor
  • Glaucoma
  • Prostaglandin analog

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Medical therapy for glaucoma: What to add after a prostaglandin analogs?'. Together they form a unique fingerprint.

  • Cite this